Sign in

Hanxuan (Astrid) Yu

@yuhanxuan.bsky.social
48 followers 59 following 13 posts

Harvard PhD student in Health Policy Decision Sciences @ctrdecisionscience.bsky.social | Previously @vumedicine.bsky.social

PostsRepliesMedia
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 19/05/2026
Excited to be presenting at #ISPORAnnual! Join us at #4076 from 11:30 AM–12:30 PM for our Top 5% finalist poster: “Estimating Productivity Loss from a Societal Perspective: A Practical Framework Using U.S. Public-Use Data” Looking forward to connecting and discussing our work with everyone!
020
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 14/04/2026
Such a pleasure to attend the @tuftscevr.bsky.social annual meeting #CEVR2026
020
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 09/04/2026
Honored to receive the award! 😊 This project will extend my previous SMDM presentation on the effect of sampling distribution shape on meta-modeling accuracy in disease simulation models.
020
Reposted by Hanxuan (Astrid) Yu
Peter Neumann @peterneumann11.bsky.social · 06/04/2026
In our new Health Affairs Scholar paper, led by Astrid Yu, we analyzed almost 7,000 cost-effectiveness analyses and found: CEAs in “most-favored nation” countries use considerably more stringent cost-effectiveness thresholds than the U.S. academic.oup.com/healthaffair... @tuftscevr.bsky.social
academic.oup.com
Cost-Effectiveness Thresholds Used in the United States versus Most Favored Nations
AbstractObjectives. Cost-effectiveness thresholds inform whether health interventions represent good value for money, yet their use varies across countries
041
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 06/04/2026
Excited to share our new paper in Health Affairs Scholar! Grateful to work with such a great team: @peterneumann11.bsky.social , David D. Kim, Josh Cohen, and @ashleyleech.bsky.social . Would love to hear your thoughts!
040
Reposted by Hanxuan (Astrid) Yu
Center for Health Decision Science (CHDS) @ctrdecisionscience.bsky.social · 09/07/2025
Members of the CHDS community contributed to the 47th Annual Meeting of the Society for Medical Decision Making (SMDM). 📰 Read more: shorturl.at/JLHHP
001
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 23/06/2025
Glad to be on board and excited to begin my #CEARegistry summer😎
021
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 18/06/2025
Photo dump coming 📸 #smdm25
010
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 18/06/2025
3rd year @smdm.bsky.social 4th presentation 1st time poster (Lusted Finalist🎉) 1st time karaoke 🎤 Grateful to mentors @jinyizhu.bsky.social @ankurfactorial.bsky.social Amazing time with peers 🍻 #smdm25
140
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 17/06/2025
Come visit my poster (#303) tomorrow at noon to see how targeted screening for subclinical atrial fibrillation can prevent strokes and save lives! #smdm25 @smdm.bsky.social @ctrdecisionscience.bsky.social
020
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 16/06/2025
Excited to join the 2025 cohort 🎉
050
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 23/05/2025
Today, the care and support I’ve received has far exceeded anything I expected—it’s renewed my optimism for the future and motivated me to dive deeper into my work. Take care!
030
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 07/02/2025
Photo dump from our cohort retreats 🥘🎿🍁🏫
000
Hanxuan (Astrid) Yu @yuhanxuan.bsky.social · 17/01/2025
New project for the new semester! Excited to work with Zach on the amazing Amua!
chds.hsph.harvard.edu
2025 Novartis Fund Awardees – Center for Health Decision ScienceHarvard T.H. Chan School of Public HealthCHDS_logo_grayscale
010
Reposted by Hanxuan (Astrid) Yu
Jinyi Zhu @jinyizhu.bsky.social · 13/01/2025
🚨Thrilled to share our new JAMA Neurology publication! Building on previous work, we compare the past vs. future impact of stroke care improvements. Timely tPA drove 20 years of gains, but untapped potential lies in carotid imaging and broader tPA access. jamanetwork.com/journals/jam...
jamanetwork.com
Acute Ischemic Stroke Care Quality Improvement
This economic evaluation analyzes retrospective and prospective data in 9 quality measures to determine their value in improving care for patients who have had a stroke.
193